{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:39:32Z","timestamp":1779377972387,"version":"3.53.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Emotional Brain BV"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The efficacy of on-demand drugs for hypoactive sexual desire disorder (HSDD) or female sexual interest\/arousal disorder (FSIAD) should be assessed using a validated instrument that assesses the discrete sexual events during which the on-demand drug is taken.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To develop and validate an event log for measuring sexual satisfaction and sexual functioning of discrete sexual events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Psychometric assessment was carried out on data of 10,959 Sexual Event Diaries (SEDs) collected during three clinical trials in a total of 421 women with HSDD. Cognitive debriefing interviews were held with 16 women with HSDD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Item scores of the SED at the event level and at the subject level, summarized item scores of women during the baseline establishment and active treatment periods, and score changes in women from baseline establishment to active treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Several items of the initial 16-item SED items showed weak validity. The 16-item SED was refined to the 11-item SED. The reliability, content, and convergent validity of the 11-item SED were confirmed. For most 11-item SED item scores, the ability to discriminate between known groups was confirmed. Larger mean score changes from the baseline establishment period were found in those with than in those without known benefit from the medication, and Guyatt effect sizes ranged from 0.73 to 1.58, thereby demonstrating the ability to detect change.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Translation<\/jats:title>\n                  <jats:p>The SED is a good tool for assessing sexual function during a discrete sexual event and for assessing the sexual function of women over longer periods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>The validation of the SED was performed on data from nearly 11,000 sexual events, gathered as part of a drug development program for HSDD and FSIAD. This amount of data provides very robust results when related to drug use for HSDD and FSIAD, but caution is advised when generalizing the validity of the SED directly to other areas of research (eg, recreational drug use and sexual risky behaviors), because such data were not used in this validation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The 11-item SED is a reliable, valid, and responsive instrument and suitable for use in evaluating the effects of on-demand drugs in women with HSDD or FSIAD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T04:47:03Z","timestamp":1507783623000},"page":"1438-1450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Sexual Event Diary (SED): Development and Validation of a Standardized Questionnaire for Assessing Female Sexual Functioning During Discrete Sexual Events"],"prefix":"10.1093","volume":"14","author":[{"given":"Yvonne","family":"van Nes","sequence":"first","affiliation":[{"name":"Emotional Brain BV , Almere, ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Bloemers","sequence":"additional","affiliation":[{"name":"Emotional Brain BV , Almere, ,","place":["The Netherlands"]},{"name":"Utrecht University \u00a0 , Utrecht, ,","place":["The Netherlands"]},{"name":"Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience \u00a0 , Utrecht, ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.M.","family":"van der Heijden","sequence":"additional","affiliation":[{"name":"Utrecht University \u00a0 \u00a0 \u00a0 , Southampton, ,","place":["UK"]},{"name":"Department of Social Sciences, Methodology and Statistics \u00a0 \u00a0 \u00a0 , Southampton, ,","place":["UK"]},{"name":"Utrecht \u00a0 \u00a0 \u00a0 , Southampton, ,","place":["UK"]},{"name":"The Netherlands and University of Southampton \u00a0 \u00a0 \u00a0 , Southampton, ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"van Rooij","sequence":"additional","affiliation":[{"name":"Emotional Brain BV , Almere, ,","place":["The Netherlands"]},{"name":"Utrecht University \u00a0 , Utrecht, ,","place":["The Netherlands"]},{"name":"Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience \u00a0 , Utrecht, ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Gerritsen","sequence":"additional","affiliation":[{"name":"Emotional Brain BV , Almere, ,","place":["The Netherlands"]},{"name":"Utrecht University \u00a0 , Utrecht, ,","place":["The Netherlands"]},{"name":"Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute of Neuroscience \u00a0 , Utrecht, ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Kessels","sequence":"additional","affiliation":[{"name":"Emotional Brain BV , Almere, ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"DeRogatis","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine, Psychiatry , Baltimore, MD ,","place":["USA"]},{"name":"Maryland Center for Sexual Health , Lutherville, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Tuiten","sequence":"additional","affiliation":[{"name":"Emotional Brain BV , Almere, ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"2024111316225100500_bib1","first-page":"2575","article-title":"Assessing sexual function in well women: validity and reliability of the Monash Women\u2019s Health Program Female Sexual Satisfaction Questionnaire","volume":"5","author":"Davison","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib2","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","edition":"4th ed."},{"key":"2024111316225100500_bib3","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed."},{"key":"2024111316225100500_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMp1513686","article-title":"FDA approval of flibanserin\u2014treating hypoactive sexual desire disorder","volume":"374","author":"Joffe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"2024111316225100500_bib5","article-title":"Efficacy and safety of on-demand use of two treatments designed for different etiologies of Female Sexual Interest\/Arousal Disorder: three randomized clinical trials","volume-title":"J Sex Med"},{"key":"2024111316225100500_bib6","first-page":"810","article-title":"Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues","volume":"10","author":"Poels","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib7","first-page":"824","article-title":"Toward personalized sexual medicine (part 3): testosterone combined with a serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms","volume":"10","author":"van Rooij","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib8","first-page":"325","article-title":"Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial","volume":"12","author":"Clayton","year":"2016","journal-title":"Womens Health"},{"key":"2024111316225100500_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2024111316225100500_bib10","article-title":"Low sexual interest, desire, and\/or arousal in women: developing drugs for treatment. Guidance for industry (draft guidance)","author":"US Department of Health and Human Services"},{"key":"2024111316225100500_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1037\/a0023353","article-title":"Dimensionality assessment of ordered polytomous items with parallel analysis","volume":"16","author":"Timmerman","year":"2011","journal-title":"Psychol Methods"},{"key":"2024111316225100500_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/152460902753668475","article-title":"Development of a sexual function questionnaire for clinical trials of female sexual dysfunction","volume":"11","author":"Quirk","year":"2002","journal-title":"J\u00a0Womens Health Gend Based Med"},{"key":"2024111316225100500_bib13","article-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988","edition":"2nd ed."},{"key":"2024111316225100500_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0021-9681(87)90069-5","article-title":"Measuring change over time: assessing the usefulness of evaluative instruments","volume":"40","author":"Guyatt","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"2024111316225100500_bib15","first-page":"429","article-title":"Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study","volume":"6","author":"van der Made","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib16","first-page":"777","article-title":"The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction","volume":"6","author":"van der Made","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib17","first-page":"1678","article-title":"The clitoral photoplethysmograph: a new way of assessing genital arousal in women","volume":"6","author":"Gerritsen","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib18","first-page":"791","article-title":"Toward personalized sexual medicine (part 1): integrating the \u201cdual control model\u201d into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder","volume":"10","author":"Bloemers","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib19","first-page":"753","article-title":"Reduced gray matter volume and increased white matter fractional anisotropy in women with hypoactive sexual desire disorder","volume":"11","author":"Bloemers","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"2024111316225100500_bib20","first-page":"616","article-title":"\u201cDid you come?\u201d A qualitative exploration of gender differences in beliefs, experiences, and concerns regarding female orgasm occurrence during heterosexual sexual interactions","volume":"51","author":"Salisbury","year":"2014","journal-title":"J\u00a0Sex Res"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951731425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951731425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/11\/1438\/60418579\/jsm_14_11_1438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/11\/1438\/60418579\/jsm_14_11_1438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:38:49Z","timestamp":1731515929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/14\/11\/1438\/6973422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,10,6]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.09.008","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2017,11,1]]},"published":{"date-parts":[[2017,10,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Sexual Event Diary (SED): Development and Validation of a Standardized Questionnaire for Assessing Female Sexual Functioning During Discrete Sexual Events","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}